INSIGHTS ON PHARMACEUTICAL PACKAGING
-
![West_GCApp_MG (person picking up container)]( "Understanding Injectable Drug Container Closure Systems")
Understanding Injectable Drug Container Closure SystemsChoosing the right container closure system (CCS) format is crucial, so understanding the different parts involved, their functions, storage requirements, and how they impact administering the drug is essential.
-
![GettyImages-546455296 film seal packaging]( "Film Sealing In Automation")
Film Sealing In AutomationExplore essential considerations for choosing the right sealing method in product development with insights on the benefits and drawbacks of different techniques for various industries.
-
![GettyImages-530489736 blister packaging]( "Integration Of Container Closure Integrity In Contract Manufacturing")
Integration Of Container Closure Integrity In Contract ManufacturingMaintaining drug product sterility and compliance demands rigorous Container Closure Integrity (CCI) within contract manufacturing. Learn how to fortify your processes.
-
![HERMA - labeling webinar]( "How To Optimize Labeling In A Pharmaceutical Environment")
How To Optimize Labeling In A Pharmaceutical EnvironmentAccurate, readable pharmaceutical labels are crucial. Learn to navigate considerations like printing, application tolerances, and inspection to select the right machinery for your production environment.
-
FAQs On The Revised EU GMP Annex 1: Volume 23/5/2025
Review the implementation of a holistic Contamination Control Strategy (CCS). Discover four key considerations for assessing component readiness: product, process, protection, and proof.
-
Microbial Challenge In-Use Studies6/13/2024
Learn more about how a partner with expertise can help you navigate the complex landscape of microbial challenge in-use studies and ensure the highest standards of patient care.
-
Find Flexibility And Scalability With Modular Assembly Equipment9/30/2025
Find tailor-made solutions designed to deliver high-quality standards even when scaling up. Modularity enhances production efficiency, saves costs, and shortens time to market.
-
Improve Speed To Market By Mitigating Vial And Stopper Incompatibility10/1/2024
These studies indicate that with a properly assembled vial containment system, good CCI performance can be achieved with stoppers of a given elastomer, independent of configuration/size, or vial style.
-
Alba® Syringe Platform: Ensuring Stability For Sensitive Drugs1/13/2025
Check out this exciting video showcasing the key advantages of Alba®: innovative coating technology that reduces potential interaction between the drug and container surface.
PHARMACEUTICAL PACKAGING SOLUTIONS
-
![GettyImages-139602926 labeling, packaging, pharma]( "Packaging Software: OEE, EBR, Track And Trace")
Werum PAS-X Packaging optimizes efficiency, compliance, and transparency in your packaging line, combining OEE monitoring, electronic batch recording, and track & trace in a single scalable system.
-
![Pharm Manufacturing Facility GettyImages-1087218874]( "Technology Transfer And Commercial Manufacturing Of Tablets And Capsules")
Finding a strategic CDMO partner that will offer tailored solutions for your late phase clinical and commercial needs, mitigate risks, and bolster your supply chain is crucial for meeting project milestones on time.
-
![Ropack]( "Pharmaceutical Contract Packaging: Quality And Technologies")
Our cutting-edge technology and impeccable standards ensure that our customers receive products that meet their exact needs.
-
![clinical-distribution]( "Pharmaceutical Clinical Trial Distribution Services")
Contracting an in-country pharmaceutical clinical depot brings efficiencies to your clinical trial distribution. From its facilities in Montreal, Quebec, Ropack handles most paperwork, permissions, components, warehousing, packaging, distribution, collection, and destruction as a single project.
-
![ROPACK.jpg]( "Contract Packaging: Pharmaceutical Solid Dose Or Generics")
A generic drug must contain the same active ingredients as the original formulation. According to the U.S. Food and Drug Administration (FDA), generic drugs are identical or within an acceptable bioequivalent range to the brand-name counterpart with respect to pharmacokinetic and pharmacodynamic properties.
